Publications (22)

2022

  1. Tumor-Homing of Mesenchymal Stem Cells Infected with Oncolytic Virus in a Canine Patient

    Veterinary Sciences, Vol. 9, Núm. 6, pp. 285

  2. Systemic cellular viroimmunotherapy for canine high-grade gliomas

    Journal for ImmunoTherapy of Cancer, Vol. 10, Núm. 12, pp. e005669

  3. Safety and Efficacy of an Oncolytic Adenovirus as an Immunotherapy for Canine Cancer Patients

    Veterinary Sciences, Vol. 9, Núm. 7

  4. Intracranial Virotherapy for a Canine Hemangioma

    International Journal of Molecular Sciences, Vol. 23, Núm. 19

2021

  1. Humoral responses to SARS-CoV-2 by healthy and sick dogs during the COVID-19 pandemic in Spain

    Veterinary Research, Vol. 52, Núm. 1

  2. AKT and JUN are differentially activated in mesenchymal stem cells after infection with human and canine oncolytic adenoviruses

    Cancer Gene Therapy, Vol. 28, Núm. 1-2, pp. 64-73

2020

  1. Humoral Response to SARS-CoV-2 by Healthy and Sick Dogs During COVID-19 Pandemic in Spain

    SSRN Electronic Journal

  2. Cellular virotherapy increases tumor-infiltrating lymphocytes (Til) and decreases their pd-1+ subsets in mouse immunocompetent models

    Cancers, Vol. 12, Núm. 7, pp. 1-17

  3. Biodistribution Analysis of Oncolytic Adenoviruses in Canine Patient Necropsy Samples Treated with Cellular Virotherapy

    Molecular Therapy - Oncolytics, Vol. 18, pp. 525-534

2019

  1. G2-S16 dendrimer microbicide does not interfere with the vaginal immune system

    Journal of Nanobiotechnology, Vol. 17, Núm. 1

  2. Enhanced antitumor efficacy of oncolytic adenovirus–loaded menstrual blood–derived mesenchymal stem cells in combination with peripheral blood mononuclear cells

    Molecular Cancer Therapeutics, Vol. 18, Núm. 1, pp. 127-138

2018

  1. Remission of spontaneous canine tumors after systemic cellular viroimmunotherapy

    Cancer Research, Vol. 78, Núm. 17, pp. 4891-4901

  2. Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice

    Cancer Immunology, Immunotherapy, Vol. 67, Núm. 10, pp. 1589-1602

2016

  1. Improved Efficiency of Ibuprofen by Cationic Carbosilane Dendritic Conjugates

    Molecular Pharmaceutics, Vol. 13, Núm. 10, pp. 3427-3438

2015

  1. Cationic dendritic systems as non-viral vehicles for gene delivery applications

    RSC Polymer Chemistry Series, Vol. 2015-January, Núm. 13, pp. 321-355

  2. Use of carbosilane dendrimer to switch macrophage polarization for the acquisition of antitumor functions

    Nanoscale, Vol. 7, Núm. 9, pp. 3857-3866

  3. Polycationic carbosilane dendrimer decreases angiogenesis and tumor-associated macrophages in tumor-bearing mice

    RSC Advances, Vol. 5, Núm. 126, pp. 104110-104115

2014

  1. HIV-1 induces B-cell activation and class switch recombination via spleen tyrosine kinase and c-Jun N-terminal kinase pathways

    AIDS, Vol. 28, Núm. 16, pp. 2365-2374

  2. Dendrimers

    RSC Nanoscience and Nanotechnology, Vol. 2014-January, Núm. 34, pp. 246-279

  3. Carbosilane dendrimers as gene delivery agents for the treatment of HIV infection

    Journal of Controlled Release, Vol. 184, Núm. 1, pp. 51-57